Latest Insider Transactions at Aclaris Therapeutics, Inc. (ACRS)
This section provides a real-time view of insider transactions for Aclaris Therapeutics, Inc. (ACRS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aclaris Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aclaris Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,000
-4.06%
|
$60,000
$10.28 P/Share
|
|
Jun 20
2023
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+25.38%
|
$16,500
$1.41 P/Share
|
|
Jun 15
2023
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
249
+0.39%
|
$249
$1.12 P/Share
|
|
Jun 02
2023
|
William D. Humphries |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+15.77%
|
-
|
|
Jun 02
2023
|
Vincent Milano |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+36.43%
|
-
|
|
Jun 02
2023
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+12.43%
|
-
|
|
Jun 02
2023
|
Maxine Gowen |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+26.81%
|
-
|
|
Jun 02
2023
|
Bryan M. Reasons |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+15.77%
|
-
|
|
Jun 02
2023
|
Andrew Kenneth William Powell |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+23.88%
|
-
|
|
Jun 02
2023
|
Andrew N Schiff |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+50.0%
|
-
|
|
Jun 02
2023
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+10.43%
|
-
|
|
Mar 17
2023
|
Douglas J. Manion Pres and CEO |
BUY
Open market or private purchase
|
Direct |
6,300
+32.98%
|
$44,100
$7.86 P/Share
|
|
Mar 09
2023
|
Douglas J. Manion Pres and CEO |
BUY
Open market or private purchase
|
Direct |
6,500
+50.0%
|
$45,500
$7.74 P/Share
|
|
Mar 03
2023
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
30,240
-2.32%
|
$362,880
$12.63 P/Share
|
|
Mar 03
2023
|
Kevin Balthaser Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
894
-14.54%
|
$10,728
$12.63 P/Share
|
|
Mar 03
2023
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
16,037
-9.79%
|
$192,444
$12.63 P/Share
|
|
Mar 02
2023
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,254
+1.38%
|
-
|
|
Mar 02
2023
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
29,000
-2.21%
|
$348,000
$12.37 P/Share
|
|
Mar 02
2023
|
Kevin Balthaser Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+19.61%
|
-
|
|
Mar 02
2023
|
Kevin Balthaser Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-17.7%
|
$12,000
$12.29 P/Share
|
|
Mar 02
2023
|
Joseph Monahan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+7.09%
|
-
|
|
Mar 02
2023
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
14,800
-8.91%
|
$177,600
$12.37 P/Share
|
|
Mar 01
2023
|
Neal Walker INTERIM CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
138,425
+3.41%
|
-
|
|
Mar 01
2023
|
Kevin Balthaser Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,950
+31.72%
|
-
|
|
Mar 01
2023
|
Joseph Monahan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
74,675
+14.04%
|
-
|
|
Feb 15
2023
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.19%
|
$65,000
$13.06 P/Share
|
|
Feb 08
2023
|
James Loerop Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,267
-37.93%
|
$55,471
$13.89 P/Share
|
|
Feb 02
2023
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.11%
|
$80,000
$16.14 P/Share
|
|
Feb 01
2023
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.07%
|
$400,000
$16.75 P/Share
|
|
Feb 01
2023
|
James Loerop Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+50.0%
|
-
|
|
Jan 04
2023
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
15,000
-1.23%
|
$210,000
$14.89 P/Share
|
|
Jan 03
2023
|
Neal Walker INTERIM CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.0%
|
$375,000
$15.68 P/Share
|
|
Dec 15
2022
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.93%
|
$75,000
$15.88 P/Share
|
|
Nov 14
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
1,371
-0.31%
|
$23,307
$17.08 P/Share
|
|
Nov 11
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
41,160
-8.63%
|
$699,720
$17.06 P/Share
|
|
Nov 10
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
11,395
-2.33%
|
$193,715
$17.02 P/Share
|
|
Nov 08
2022
|
Andrew Kenneth William Powell |
SELL
Bona fide gift
|
Direct |
4,000
-28.87%
|
-
|
|
Oct 26
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
14,540
-2.89%
|
$247,180
$17.0 P/Share
|
|
Oct 25
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
12,018
-2.33%
|
$204,306
$17.02 P/Share
|
|
Oct 24
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
14,616
-2.76%
|
$248,472
$17.01 P/Share
|
|
Oct 18
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
32,093
-5.71%
|
$513,488
$16.89 P/Share
|
|
Oct 17
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
19,944
-3.43%
|
$319,104
$16.05 P/Share
|
|
Oct 17
2022
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.7%
|
$75,000
$15.98 P/Share
|
|
Oct 07
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
7,324
-1.24%
|
$117,184
$16.16 P/Share
|
|
Oct 06
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
37,839
-6.04%
|
$605,424
$16.54 P/Share
|
|
Oct 04
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Indirect |
7,700
-1.21%
|
$123,200
$16.01 P/Share
|
|
Jun 17
2022
|
Andrew N Schiff |
SELL
Open market or private sale
|
Direct |
19,565
-100.0%
|
$293,475
$15.14 P/Share
|
|
Jun 03
2022
|
Maxine Gowen |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+30.1%
|
-
|
|
Jun 03
2022
|
William D. Humphries |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+14.64%
|
-
|
|
Jun 03
2022
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+8.94%
|
-
|